164 related articles for article (PubMed ID: 19262092)
1. Elevated cell invasion is induced by hypoxia in a human pituitary adenoma cell line.
Yoshida D; Teramoto A
Cell Adh Migr; 2007; 1(1):43-51. PubMed ID: 19262092
[TBL] [Abstract][Full Text] [Related]
2. Expression of laminin beta2: a novel marker of hypoxia in pituitary adenomas.
Bao Y; Yoshida D; Morimoto D; Teramoto A
Endocr Pathol; 2006; 17(3):251-61. PubMed ID: 17308362
[TBL] [Abstract][Full Text] [Related]
3. The CXCR4 antagonist AMD3100 suppresses hypoxia-mediated growth hormone production in GH3 rat pituitary adenoma cells.
Yoshida D; Koketshu K; Nomura R; Teramoto A
J Neurooncol; 2010 Oct; 100(1):51-64. PubMed ID: 20309720
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of pituitary adenoma cell invasion and adhesion is mediated by discoidin domain receptor-1.
Yoshida D; Teramoto A
J Neurooncol; 2007 Mar; 82(1):29-40. PubMed ID: 17001518
[TBL] [Abstract][Full Text] [Related]
5. Effect of Hypoxia on DDR1 Expression in Pituitary Adenomas.
Li S; Zhang Z; Xue J; Guo X; Liang S; Liu A
Med Sci Monit; 2015 Aug; 21():2433-8. PubMed ID: 26286316
[TBL] [Abstract][Full Text] [Related]
6. Regulation of cell invasion and signalling pathways in the pituitary adenoma cell line, HP-75, by reversion-inducing cysteine-rich protein with kazal motifs (RECK).
Yoshida D; Nomura R; Teramoto A
J Neurooncol; 2008 Sep; 89(2):141-50. PubMed ID: 18493720
[TBL] [Abstract][Full Text] [Related]
7. Anti-apoptotic action by hypoxia inducible factor 1-alpha in human pituitary adenoma cell line, HP-75 in hypoxic condition.
Yoshida D; Kim K; Noha M; Teramoto A
J Neurooncol; 2006 Jul; 78(3):217-25. PubMed ID: 16779673
[TBL] [Abstract][Full Text] [Related]
8. Expression of cold-inducible RNA-binding protein (CIRP) in pituitary adenoma and its relationships with tumor recurrence.
Wang M; Zhang H; Heng X; Pang Q; Sun A
Med Sci Monit; 2015 May; 21():1256-60. PubMed ID: 25934796
[TBL] [Abstract][Full Text] [Related]
9. Elevation of growth hormone-releasing hormone receptor messenger ribonucleic acid expression in growth hormone-secreting pituitary adenoma with Gsalpha protein mutation.
Sakai N; Kim K; Sanno N; Yoshida D; Teramoto A; Shibasaki T
Neurol Med Chir (Tokyo); 2008; 48(11):481-7; discussion 487-8. PubMed ID: 19029774
[TBL] [Abstract][Full Text] [Related]
10. Relationship between RSUME and HIF-1α/VEGF-A with invasion of pituitary adenoma.
He W; Huang L; Shen X; Yang Y; Wang D; Yang Y; Zhu X
Gene; 2017 Mar; 603():54-60. PubMed ID: 27989771
[TBL] [Abstract][Full Text] [Related]
11. Cobalt chloride-induced hypoxia modulates the invasive potential and matrix metalloproteinases of primary and metastatic breast cancer cells.
Fu OY; Hou MF; Yang SF; Huang SC; Lee WY
Anticancer Res; 2009 Aug; 29(8):3131-8. PubMed ID: 19661326
[TBL] [Abstract][Full Text] [Related]
12. [Role of matrix metalloproteinases-9, 2 and their inhibitor-TIMP-1, 2 in invasive pituitary adenomas biological behavior].
He DS; Chen MZ; Wang HJ; Ke CL; Yan C; Zheng H; Hong YS
Ai Zheng; 2002 Oct; 21(10):1124-8. PubMed ID: 12508658
[TBL] [Abstract][Full Text] [Related]
13. Alternative splicing of iodothyronine deiodinases in pituitary adenomas. Regulation by oncoprotein SF2/ASF.
Piekielko-Witkowska A; Kedzierska H; Poplawski P; Wojcicka A; Rybicka B; Maksymowicz M; Grajkowska W; Matyja E; Mandat T; Bonicki W; Nauman P
Biochim Biophys Acta; 2013 Jun; 1832(6):763-72. PubMed ID: 23462647
[TBL] [Abstract][Full Text] [Related]
14. Regulating effect of MMP-9 and TIMP-1 in pituitary adenoma invasion.
Mao JH; Guo H; Si N; Qiu L; Guo LF; Sun ZS; Xiang Y; Yang XH; Zhao WG; Zhang WC
Genet Mol Res; 2015 Dec; 14(4):17091-8. PubMed ID: 26681056
[TBL] [Abstract][Full Text] [Related]
15. Tissue inhibitors of metalloproteinase-expressing cells in human anterior pituitary and pituitary adenoma.
Tofrizal A; Fujiwara K; Azuma M; Kikuchi M; Jindatip D; Yashiro T; Yamada S
Med Mol Morphol; 2017 Sep; 50(3):145-154. PubMed ID: 28353090
[TBL] [Abstract][Full Text] [Related]
16. Functional analysis of matrix metalloproteinases and tissue inhibitors of metalloproteinases differentially expressed by variants of human HT-1080 fibrosarcoma exhibiting high and low levels of intravasation and metastasis.
Partridge JJ; Madsen MA; Ardi VC; Papagiannakopoulos T; Kupriyanova TA; Quigley JP; Deryugina EI
J Biol Chem; 2007 Dec; 282(49):35964-77. PubMed ID: 17895241
[TBL] [Abstract][Full Text] [Related]
17. Stromal cell-derived factor-1 expression in pituitary adenoma tissues and upregulation in hypoxia.
Nomura R; Yoshida D; Teramoto A
J Neurooncol; 2009 Sep; 94(2):173-81. PubMed ID: 19280118
[TBL] [Abstract][Full Text] [Related]
18. 3-phosphoinositide-dependent protein kinase-1 (PDK1) promotes invasion and activation of matrix metalloproteinases.
Xie Z; Yuan H; Yin Y; Zeng X; Bai R; Glazer RI
BMC Cancer; 2006 Mar; 6():77. PubMed ID: 16551362
[TBL] [Abstract][Full Text] [Related]
19. Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential.
Figueira RC; Gomes LR; Neto JS; Silva FC; Silva ID; Sogayar MC
BMC Cancer; 2009 Jan; 9():20. PubMed ID: 19144199
[TBL] [Abstract][Full Text] [Related]
20. Effects of hepatocyte growth factor on the expression of matrix metalloproteinases and their tissue inhibitors during the endometrial cancer invasion in a three-dimensional coculture.
Park YH; Ryu HS; Choi DS; Chang KH; Park DW; Min CK
Int J Gynecol Cancer; 2003; 13(1):53-60. PubMed ID: 12631221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]